Walkersville, MD / Basel, Switzerland, 12 June 2014 – Lonza QC Testing Solutions announces the launch of its new technical showcase page on LinkedIn®. As an extension of Lonza’s company page, the QC Testing Solutions showcase page offers curated content for QC Testing professionals to help them overcome challenges they face in a regulated environment. Interested QC professionals will be able to stay up to date on the most relevant QC topics by following https://www.linkedin.com/company/lonza-qc-testing-solutions.
“By sharing our endotoxin detection knowledge and expertise through LinkedIn®, we can get closer to our customers, understand their needs and offer solutions to help make their QC testing processes more efficient,” Katrin Hoeck, Head of Marketing, Cell Analysis and Testing, Lonza Pharma – Bioscience Solutions, explained. Hoeck invites followers to regularly engage and submit their topics of interest via the new QC Testing Solutions showcase page.
Lonza is aware of the importance of the horseshoe crab for its contribution to the safety of drugs and medical devices but also its ecological role. For each new QC Testing Solutions LinkedIn® follower, Lonza donates to ERDG, the Ecological Research and Development Group, a non-profit wildlife organization whose primary focus is the conservation of the world’s four horseshoe crab species.
About Lonza Pharma&Biotech ̶ Bioscience Solutions
Lonza provides the pharma market with the tools life science researchers use to develop and test therapeutics, from basic research to final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software to ensure product quality. Lonza Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions. Lonza is the trusted QC testing solution provider for the pharmaceutical and medical device industries. Lonza transforms its practical knowledge and technical expertise to deliver a portfolio of endotoxin, mycoplasma and microbial detection products, as well as paperless QC microbiology, software and services that support the critical needs of regulated manufacturing environments.
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 10,000 employees worldwide. The company generated sales of about CHF 3.6 billion in 2013 and is organized into two market- focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges. Further information can be found at www.lonza.com.
Further Information:
Lonza Cologne GmbH
Marketing Communications and Product PR
Corinna König-Wildförster
Phone: +49 221 99199 464
[email protected]
Lonza Group AG
Media Relations
Constance Ward
Phone +41 61 316 8840
[email protected]